TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Control Bionics Ltd. ( (AU:CBL) ) is now available.
Control Bionics Limited announced a change in the director’s interest, with Jeremy Steele acquiring 8 million additional options, increasing his total to over 12 million options. This move, approved at the 2025 AGM, reflects a strategic alignment with the company’s growth objectives and may influence investor confidence and stakeholder engagement.
The most recent analyst rating on (AU:CBL) stock is a Hold with a A$0.07 price target. To see the full list of analyst forecasts on Control Bionics Ltd. stock, see the AU:CBL Stock Forecast page.
More about Control Bionics Ltd.
Control Bionics Limited operates in the technology industry, focusing on developing and providing assistive communication devices. These products are designed to enhance communication capabilities for individuals with disabilities, positioning the company as a significant player in the assistive technology market.
Average Trading Volume: 1,055,791
Technical Sentiment Signal: Buy
Current Market Cap: A$23.33M
Find detailed analytics on CBL stock on TipRanks’ Stock Analysis page.